» Articles » PMID: 25658535

Shift in Serotype Distribution of Shigella Species in China, 2003-2013

Overview
Publisher Elsevier
Date 2015 Feb 7
PMID 25658535
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

We identified 2912 Shigella isolates from diarrhoeal patients in China during 2003-2013. The most common species was Shigella flexneri (55.3%), followed by Shigella sonnei (44.1%); however, S. sonnei is becoming increasingly prevalent. Among the S. flexneri isolates, serotypes 2a and X variant (-:7,8, E1037) were the two most prevalent serotypes, and serologically atypical isolates were also commonly identified. Overall, S. sonnei, S. flexneri 2a and S. flexneri X variant (-:7,8, E1037) accounted for 76.1% of all Shigella isolates, and their prevalence increased from 54.0% during 2003-2004 to 84.1% during 2011-2013. A change was observed in the serotype distribution of Shigella in China during this period, and we propose an ideal strategy to inform the development of a broadly effective Shigella vaccine candidate.

Citing Articles

and infection in led to species-specific regulatory responses in the host and pathogen.

Wong B, Tan H Microb Genom. 2025; 11(1).

PMID: 39853209 PMC: 11893279. DOI: 10.1099/mgen.0.001339.


Antibiotic resistance and serotype distribution of strains in Bangladesh over the period of 2014-2022: evidence from a nationwide hospital-based surveillance for cholera and other diarrheal diseases.

Afrad M, Islam M, Begum Y, Saifullah M, Ahmmed F, Khan Z Microbiol Spectr. 2024; :e0073924.

PMID: 39540737 PMC: 11619575. DOI: 10.1128/spectrum.00739-24.


A Shigella sonnei clone with extensive drug resistance associated with waterborne outbreaks in China.

Qiu S, Liu K, Yang C, Xiang Y, Min K, Zhu K Nat Commun. 2022; 13(1):7365.

PMID: 36450777 PMC: 9709761. DOI: 10.1038/s41467-022-35136-1.


Rapid generation of Shigella flexneri GMMA displaying natural or new and cross-reactive O-Antigens.

Gasperini G, Raso M, Schiavo F, Aruta M, Ravenscroft N, Bellich B NPJ Vaccines. 2022; 7(1):69.

PMID: 35773292 PMC: 9243986. DOI: 10.1038/s41541-022-00497-7.


Shigella-Controlled Human Infection Models: Current and Future Perspectives.

Clarkson K, Porter C, Talaat K, Kapulu M, Chen W, Frenck Jr R Curr Top Microbiol Immunol. 2022; 445:257-313.

PMID: 35616717 PMC: 7616482. DOI: 10.1007/82_2021_248.